Other substances

Alvimopan

An opioid μ receptor antagonist.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

Alvimopan on PubChem

Marketed as

ALVIMOPAN; ENTEREG

 

Structure image - Alvimopan

C[C@H]1CN(CC[C@@]1(C)C2=CC(=CC=C2)O)C[C@H](CC3=CC=CC=C3)C(=O)NCC(=O)O

Supporting references

Link Tested on Impact factor Notes Publication date
A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing
3CLpro Nucleocapsid protein nsp16 nsp10 Small molecule In silico 		in silico 2.74

Predicted to bind SARS-CoV-2 nsp10-nsp16 protein complex.

 Mar/18/2021
Export (.csv)